Previous Article | Next Article 
Infection and Immunity, October 2001, p. 6004-6011, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6004-6011.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of the Enzymatic Component of the
ADP-Ribosyltransferase Toxin CDTa from Clostridium
difficile
Irene
Gülke,
Gunther
Pfeifer,
Jan
Liese,
Michaela
Fritz,
Fred
Hofmann,
Klaus
Aktories, and
Holger
Barth*
Institut für Experimentelle und
Klinische Pharmakologie und Toxikologie der
Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg,
Germany
Received 12 April 2001/Returned for modification 22 May
2001/Accepted 19 June 2001
Certain strains of Clostridium difficile produce the
ADP-ribosyltransferase CDT, which is a binary actin ADP-ribosylating toxin. The toxin consists of the binding component CDTb, which mediates
receptor binding and cellular uptake, and the enzyme component CDTa.
Here we studied the enzyme component (CDTa) of the toxin using the
binding component of Clostridium perfringens iota toxin
(Ib), which is interchangeable with CDTb as a transport component. Ib
was used because CDTb was not expressed as a recombinant protein in
Escherichia coli. Similar to iota toxin, CDTa
ADP-ribosylates nonmuscle and skeletal muscle actin. The N-terminal
part of CDTa (CDTa1-240) competes with full-length CDTa
for binding to the iota toxin binding component. The C-terminal part
(CDTa244-263) harbors the enzyme activity but was much
less active than the full-length CDTa. Changes of Glu428 and Glu430 to
glutamine, Ser388 to alanine, and Arg345 to lysine blocked
ADP-ribosyltransferase activity. Comparison of CDTa with C.
perfringens iota toxin and Clostridium botulinum
C2 toxin revealed full enzyme activity of the fragment
Ia208-413 but loss of activity of several N-terminally
deleted C2I proteins including C2I103-431,
C2I190-431, and C2I30-431. The data indicate
that CDTa belongs to the iota toxin subfamily of binary actin
ADP-ribosylating toxins with respect to interaction with the binding
component and substrate specificity. It shares typical conserved amino
acid residues with iota toxin and C2 toxin that are suggested to be
involved in NAD-binding and/or catalytic activity. The enzyme
components of CDT, iota toxin, and C2 toxin differ with respect
to the minimal structural requirement for full enzyme activity.
*
Corresponding author. Mailing address: Institut
für Experimentelle und Klinische Pharmakologie und Toxikologie,
Hermann-Herder-Str. 5, D-79104 Freiburg, Germany. Phone:
49-0761-2035301. Fax: 49-0761-2035311. E-mail:
barthh{at}uni-freiburg.de.

Present address: Institut für Toxikologie der Medizinischen
Hochschule Hannover, D-30623 Hannover,
Germany.
Infection and Immunity, October 2001, p. 6004-6011, Vol. 69, No. 10
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6004-6011.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Neumeyer, T., Schiffler, B., Maier, E., Lang, A. E., Aktories, K., Benz, R.
(2008). Clostridium botulinum C2 Toxin: IDENTIFICATION OF THE BINDING SITE FOR CHLOROQUINE AND RELATED COMPOUNDS AND INFLUENCE OF THE BINDING SITE ON PROPERTIES OF THE C2II CHANNEL. J. Biol. Chem.
283: 3904-3914
[Abstract]
[Full Text]
-
Keel, M. K., Songer, J. G.
(2006). The Comparative Pathology of Clostridium difficile-associated Disease. Vet Pathol
43: 225-240
[Abstract]
[Full Text]
-
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C. Jr., Kazakova, S. V., Sambol, S. P., Johnson, S., Gerding, D. N.
(2005). An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. NEJM
353: 2433-2441
[Abstract]
[Full Text]
-
Voth, D. E., Ballard, J. D.
(2005). Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin. Microbiol. Rev.
18: 247-263
[Abstract]
[Full Text]
-
Alonso, R, Martin, A, Pelaez, T, Marin, M, Rodriguez-Creixems, M, Bouza, E
(2005). Toxigenic status of Clostridium difficile in a large Spanish teaching hospital. J Med Microbiol
54: 159-162
[Abstract]
[Full Text]
-
Barbut, F., Decre, D., Lalande, V., Burghoffer, B., Noussair, L., Gigandon, A., Espinasse, F., Raskine, L., Robert, J., Mangeol, A., Branger, C., Petit, J.-C.
(2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol
54: 181-185
[Abstract]
[Full Text]
-
Pituch, H., Kreft, D., Obuch-Woszczatynski, P., Wultanska, D., Meisel-Mikolajczyk, F., Luczak, M., van Belkum, A.
(2005). Clonal Spread of a Clostridium difficile Strain with a Complete Set of Toxin A, Toxin B, and Binary Toxin Genes among Polish Patients with Clostridium difficile-Associated Diarrhea. J. Clin. Microbiol.
43: 472-475
[Abstract]
[Full Text]
-
Terhes, G., Urban, E., Soki, J., Hamid, K. A., Nagy, E.
(2004). Community-Acquired Clostridium difficile Diarrhea Caused by Binary Toxin, Toxin A, and Toxin B Gene-Positive Isolates in Hungary. J. Clin. Microbiol.
42: 4316-4318
[Abstract]
[Full Text]
-
Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G.
(2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev.
68: 373-402
[Abstract]
[Full Text]
-
Haug, G., Aktories, K., Barth, H.
(2004). The Host Cell Chaperone Hsp90 Is Necessary for Cytotoxic Action of the Binary Iota-Like Toxins. Infect. Immun.
72: 3066-3068
[Abstract]
[Full Text]
-
Goncalves, C., Decre, D., Barbut, F., Burghoffer, B., Petit, J.-C.
(2004). Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol.
42: 1933-1939
[Abstract]
[Full Text]
-
Wilkins, T. D., Lyerly, D. M.
(2003). Clostridium difficile Testing: after 20 Years, Still Challenging. J. Clin. Microbiol.
41: 531-534
[Full Text]